Propranolol
Back to searchMolecule Structure
Scientific Name
Propranolol
Description of the Drug
Propranolol is a non-selective beta adrenergic antagonist used to treat hypertension, angina, atrial fibrillation, myocardial infarction, migraine, essential tremor, hypertrophic subaortic stenosis, and pheochromocytoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00571
http://www.drugbank.ca/drugs/DB00571
Brand Name(s)
Not Available
Company Owner(s)
Pierre Fabre Dermatologie, Dava Pharmaceuticals Inc, Schering Corp Sub Schering Plough Corp, Solopak Medical Products Inc, Watson Laboratories Inc, Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3955 | ||||
PharmGKB | PA451145 | ||||
Human Metabolome Database | HMDB0001849 | ||||
DrugBank | DB00571 | ||||
PubChem: Thomson Pharma | 14823711 | ||||
PubChem | 4946 | ||||
Mcule | MCULE-7804628650 | ||||
NMRShiftDB | 60025561 | ||||
LINCS | LSM-4329 | ||||
Nikkaji | J6.653B | ||||
BindingDB | 25761 | ||||
EPA CompTox Dashboard | DTXSID6023525 | ||||
DrugCentral | 2303 | ||||
Metabolights | MTBLC8499 | ||||
Brenda | 5606 | 66047 | 45500 | 3905 | |
ChemicalBook | CB63039539 | CB0875381 | |||
Guide to Pharmacology | 564 | ||||
rxnorm | INDERAL | PROPRANOLOL HYDROCHLORIDE | INNOPRAN | HEMANGEOL | PROPRANOLOL |
KEGG Ligand | C07407 | ||||
ChEBI | 8499 |